Paracrine sonic hedgehog signalling by prostate cancer cells induces osteoblast differentiation
© Zunich et al; licensee BioMed Central Ltd. 2009
Received: 07 November 2008
Accepted: 02 March 2009
Published: 02 March 2009
Sonic hedgehog (Shh) and components of its signalling pathway have been identified in human prostate carcinoma and increased levels of their expression appear to correlate with disease progression and metastasis. The mechanism through which Shh signalling could promote metastasis in bone, the most common site for prostate carcinoma metastasis, has not yet been investigated. The present study determined the effect of Shh signalling between prostate cancer cells and pre-osteoblasts on osteoblast differentiation, a requisite process for new bone formation that characterizes prostate carcinoma metastasis.
LNCaP human prostate cancer cells modified to overexpress Shh (designated LNShh cells) and MC3T3 mouse pre-osteoblasts were maintained as mixed populations within the same culture chamber. In this non-conventional mixed culture system, LNShh cells upregulated the expression of Shh target genes Gli1 and Patched 1 (Ptc1) in MC3T3 cells and this was inhibited by cyclopamine, a specific chemical inhibitor of hedgehog signalling. Concomitantly, MC3T3 cells exhibited time-dependent decreased cell proliferation, upregulated alkaline phosphatase Akp2 gene expression, and increased alkaline phosphatase activity indicative of early phase osteoblast differentiation. LNShh cell-induced differentiation was inhibited in MC3T3 cells stably transfected with a dominant negative form of Gli1, a transcription factor that mediates Shh signalling. Interestingly, LNShh cells did not significantly increase the endogenous expression of the osteoblast differentiation transcription factor Runx2 and its target genes osteocalcin and osteopontin. Consistent with these results, exogenous Shh peptide did not upregulate Runx2 expression in MC3T3 cells. However, Runx2 levels were increased in MC3T3 cells by ascorbic acid, a known stimulator of osteoblast differentiation.
Altogether, these data demonstrate that Shh-expressing prostate cancer cells can directly and specifically induce differentiation in pre-osteoblasts via a Gli1-dependent mechanism that does not require transcriptional upregulation of Runx2. Paracrine activation of the Shh pathway in osteoblast progenitors and subsequent induction of osteoblast differentiation could be a mechanism through which high levels of Shh expression in prostate carcinoma contribute to bone metastasis. Targeting of paracrine Shh signalling may provide an effective therapeutic strategy against prostate carcinoma metastasis in bone.
Bone is the most common site for metastasis of prostate carcinoma affecting as many as 90% of patients with metastatic disease . Complications from skeletal metastasis result in a dramatic reduction in the patient's quality of life and invariably lead to death [2, 3]. A clear understanding of the factors and mechanisms that promote the migration of prostate cancer cells to bone, their colonization of the bone environment and subsequent formation of metastases is critically needed to prevent and effectively treat this disease. The commonly held "seed and soil" theory emphasizes the importance of the bone microenvironment in determining the colonization success of neoplastic "seed" cells . On the other hand, prostate cancer cells can alter gene expression and cell functions in osteoblasts, suggesting that invading tumor cells might also influence the host bone milieu making it a favourable "soil" for metastasis [5, 6]. This latter view fuels the on-going search for factors secreted by prostate cancer cells that might uniquely signal to bone and promote metastases.
Sonic hedgehog (Shh) is a secreted glycopeptide that plays essential functions in development and disease [7, 8]. The binding of Shh to its transmembrane receptor Patched 1 (Ptc1) triggers the release of the transmembrane protein Smoothened (Smo) from Ptc1-mediated inhibition. Subsequent activation of the intracellular signalling cascade leads to the transcriptional regulation of Shh target genes by the Gli family of transcription factors: Gli1, Gli2, and Gli3.
Shh and members of its signalling pathway are expressed in prostate carcinoma and increased levels of their expression appear to correlate with cancer progression and metastasis [9–12]. Shh expression has been localized in prostatic epithelia or glandular lumens of prostate tumors indicating that epithelial-derived prostate cancer cells are a primary if not sole source of the Shh protein [9, 11].
We have shown previously that Shh-expressing human prostate cancer cells upregulated Gli1 expression in surrounding tumor stroma and accelerated tumor growth in a mouse xenograft model of human prostate cancer . This apparent paracrine activation of the pathway in prostate tumorigenesis is highly reminiscent of Shh-Gli signalling at epithelial-mesenchymal boundaries in several developing organ systems including the prostate that promotes cell proliferation and morphogenesis [13, 14].
The mechanism by which Shh-Gli signalling could promote prostate carcinoma metastasis in bone has not been previously determined. The present study provides evidence of direct and specific paracrine Shh-Gli signalling between prostate cancer cells and pre-osteoblasts which leads to osteoblast differentiation, a requisite process for osteoblastic metastasis.
Shh-expressing human prostate cancer cells, LNShh, directly activate hedgehog signalling in MC3T3 pre-osteoblasts
Paracrine interactions between cells have traditionally been studied in vitro by co-culturing cells in separate chambers while sharing the same culture medium. We have developed a non-conventional mixed culture system where different cell populations are cultured within the same chamber, thus, allowing them to establish physical associations that most likely occur in vivo and influence cell-cell signalling.
Sequences (5'- 3') of primers and probes used in quantitative real time RT-PCR analysis of mouse (m) and human (h) gene expression.
Cyclopamine, a specific chemical inhibitor of hedgehog signalling through functional inhibition of the Shh receptor complex protein Smo, dramatically abrogated the increase in both Gli1 and Ptc1 expression in MC3T3 cells in mixed culture with LNShh cells (Figure 2C). Activation of the hedgehog pathway in MC3T3 cells was a direct and immediate effect of Shh action since exogenous Shh peptide (Shh-N) increased Gli1 and Ptc1 message as early as 24 h following treatment (Figure 2D).
These data demonstrate specific and direct paracrine activation of Shh signalling in pre-osteoblasts by Shh-expressing prostate cancer cells.
LNShh cells induce early phase osteoblast differentiation
Cell proliferation arrest is associated with a time-dependent increase in alkaline phosphatase (ALP) activity, a well-established indicator of osteoblast differentiation . ALP activity in mixed cultures of MC3T3 and LNShh cells increased with time and was significantly higher relative to that in mixed cultures of MC3T3 and control LNCaP cells (Figure 3B). Staining for ALP activity was performed to determine the spatial localization of activity in mixed cultures. Consistent with data shown in Figure 3B, staining for ALP activity was greater in mixed cultures of LNShh and MC3T3 cells and intensified progressively through time (Figure 3C). Staining for ALP activity was localized almost exclusively in MC3T3 cells which surrounded clusters of LNShh cells (Figure 3C). Single cultures of MC3T3 cells also exhibited ALP staining when grown to confluence (data not shown).
Correspondingly, expression of the alkaline phosphatase gene Akp2, an early osteoblast differentiation marker gene, was increased in MC3T3 cells in mixed culture with LNShh cells, and this effect was mimicked by direct treatment of MC3T3 cells with exogenous Shh-N (Figures 3D and 3E, respectively).
MC3T3 cells in mixed culture with either control LNCaP or LNShh cells in ascorbic acid (AA)-free α-MEM media for 21 days were negative for both Alizarin red and Von Kossa staining indicating the absence of significant calcium deposition in and mineralization of the extracellular matrix (ECM), respectively (data not shown). These results are consistent with the known requirement for AA and inorganic phosphates for ECM mineralization during late stage osteoblast differentiation.
Gli1 transcriptional activity is required for LNShh cell-induced osteoblast differentiation
To establish that LNShh cell-induced osteoblast differentiation occurred via the Shh signalling pathway, MC3T3 cells were stably transfected with human GLI1 cDNA which has a deletion in the region containing the t rans a ctivation d omain: pCMV-GLI(-)TAD . The translated GLI1 protein in transfected MC3T3 cells, designated as M-TAD cells, is expected to bind to the consensus DNA Gli binding site but not activate the pathway, thus, acting as a dominant negative form of the Shh signalling transcription factor.
Expression of the dominant negative GLI1 effectively blocked the activation of the Shh pathway and inhibited the upregulation of Gli1 and Ptc1 in M-TAD cells cultured with LNShh cells (Figure 4C). Consequently, M-TAD cells cultured with LNShh cells for 14 days exhibited markedly decreased Akp2 expression (data not shown) and ALP activity (Figure 4D, panels a, b and c). Hematoxylin staining of mixed cultures following staining for ALP activity showed confluent populations of both MC3T3 and M-TAD cells in mixed cultures with LNShh cells indicating that the decrease in ALP activity in M-TAD cells was not a function of differences in cell confluence in the co-cultures (Figure 4D, panels d, e and f).
LNShh cells do not upregulate the expression of Runx2
Consistent with these data, activation of the Shh pathway in MC3T3 cells by exogenous Shh-N, as evidenced by increased expression in Gli1 and Ptc1, did not upregulate Runx2 expression (Figure 5B). On the other hand, exogenous AA significantly increased Runx2 levels in MC3T3 cells without activating the Shh pathway (Figure 5B). Combined stimulation with Shh-N and AA did not significantly increase the expression of Runx2 relative to treatment with AA alone, or the expression of Shh target genes Gli1 and Ptc1 relative to treatment with Shh-N alone indicating the absence of synergistic interaction between these two factors. AA upregulates the expression of osteoblast differentiation marker genes including Runx2 and promotes osteoblast differentiation [19, 20]. These data, therefore, indicate that early phase osteoblast differentiation in pre-osteoblasts induced by paracrine Shh signalling might proceed in a mechanism that does not require the transcriptional regulation of Runx2.
The functional relevance of upregulated Shh expression in human prostate carcinoma to the development of bone metastasis has not been previously investigated. We now provide data which indicate that prostate cancer cells that express high levels of Shh can directly and specifically activate the signalling pathway in osteoblast progenitors and induce osteoblast differentiation, an essential process in new bone formation that characterizes prostate carcinoma metastasis.
LNCaP human prostate cancer cells genetically engineered to overexpress Shh (designated LNShh cells) upregulated the expression of Shh-responsive target genes Gli1 and Ptc1 in co-cultured MC3T3 mouse pre-osteoblasts and this action was inhibited by cyclopamine, a specific chemical inhibitor of hedgehog signalling, and mimicked by exogenous Shh peptide. LNShh cell-induced activation of the Shh signalling pathway in pre-osteoblasts led to the induction of early phase osteoblast differentiation characterized by abrogated cell proliferation and increased expression and activity of alkaline phosphatase. Conversely, failure to activate the Shh pathway by a dominant negative form of the transcription factor Gli1 in pre-osteoblasts inhibited LNShh cell-induced osteoblast differentiation. These data confirm previous findings which have demonstrated a role for the hedgehog proteins, Shh and Indian hedgehog (Ihh), in osteoblast differentiation [21–27].
Ihh, Ptc1, Smo, Gli1, Gli2, and Gli3 are expressed in developing bone, and hedgehog signalling plays a vital role in skeletal development [28–35]. The expression of Ptc1, Smo, and Gli1 in perichondrial cells adjacent to Ihh-expressing prehypertropic chondrocytes strongly suggests a paracrine pathway through which hedgehog signalling might induce differentiation of perichondrial cells into osteoblasts during endochondral bone formation [21, 30, 34, 35].
Our data suggest that the apparent paracrine pathway of hedgehog signalling in bone development may be recapitulated in bone metastasis where Shh-expressing prostate cancer cells activate the pathway in osteoblast progenitors and induce osteoblast differentiation. Reciprocally, differentiated osteoblasts might provide factors that are favourable to tumor growth in bone. Many identified downstream target genes of Gli1 transcriptional activity are known to regulate cell proliferation and cell adhesion .
The downstream mechanism through which Shh signalling induces osteoblast differentiation is not fully understood. Runx2 (also known as Cbfa1: core-binding factor 1) encodes a major and critical transcription activator of osteoblast differentiation [17, 37, 38]. A recent study has demonstrated that Ihh promotes osteoblast differentiation in multipotent mesenchymal cells C3H10T1/2 by upregulating the expression and function of Runx2 through the transcriptional action of Gli2 . Our data, however, show that LNShh cell-induced early phase differentiation in MC3T3 pre-osteoblasts was not accompanied by a significant increase in endogenous levels of Runx2 and its downstream target genes Ocn and Opn. Moreover, exogenous Shh-N did not directly upregulate Runx2 expression in MC3T3 cells; whereas, the osteoblast differentiation factor AA increased Runx2 levels in MC3T3 cells without activating the Shh pathway. These data suggest that in cells that are already committed to the osteoblast lineage and express endogenous levels of Runx2, as is the case with MC3T3 cells, the induction of osteoblast differentiation by Shh signalling occurs through a mechanism that does not require further transcriptional upregulation of Runx2. Similarly, Xiao and co-workers concluded that osteoblast differentiation induced by bone morphogenetic protein (BMP) in mature osteoblast precursors does not require increased expression of Cbfa1 (Runx2) but might involve posttranscriptional regulation of the Runx2 protein . In multipotent mesenchymal progenitors, however, Shh signalling promotes osteoblast commitment and differentiation through the upregulation of Runx2 message and activity [27, 40].
Shh may act in concert with other factors in regulating osteoblast differentiation. Prostate cancer cells secrete signalling ligands including growth factors, bone morphogenetic proteins, and parathyroid hormone-related protein which are known to regulate osteoblast functions and whose actions have been linked to hedgehog signalling [5, 6, 24, 41, 42]. More studies are needed to tease out the functional interplay between hedgehog signalling and other pathways in the development of prostate carcinoma metastasis in bone.
Prostate cancer cells that metastasize to bone or those that are directly injected in bone in animal models will be in close physical contact with bone stromal cells including bone cells and their osteoblast progenitors, fibroblasts, hematopoetic cells, and multipotent mesenchymal stem cells. In the presence of mixed cell populations within the bone environment, it is difficult to isolate and determine direct cell-cell interactions that might impact the development of prostate carcinoma metastasis. The non-conventional mixed culture system developed in these studies provides an excellent in vitro model to investigate early outcomes of paracrine signalling between defined cell populations and to evaluate how these interactions might be impacted by other signalling pathways and/or therapeutic interventions.
This study presents evidence that Shh-expressing prostate cancer cells directly and specifically activate the Shh signalling pathway in pre-osteoblasts. Paracrine Shh signalling in pre-osteoblasts leads to osteoblast differentiation via a Gli1-dependent mechanism that does not require transcriptional upregulation of endogenous Runx2 expression. These data provide a mechanism through which increased levels of Shh in human prostate carcinoma might specifically promote bone metastasis.
LNCaP human prostate cancer cells (ATCC, Rockville, MD) have been previously stably transfected with a 1.44 kb human Shh cDNA cloned into a pIRES2-EGFP mammalian cell expression vector (designated as LNShh cells) or with pIRES2-EGFP vector alone . LNShh and control LNCaP cells were maintained at 37C, 5% CO2 in complete culture medium consisting of RPMI-1640 supplemented with 10% fetal bovine serum (FBS), 100 U/ml penicillin and 100 μg/ml streptomycin (Gibco Invitrogen). Shh gene and protein expression were routinely determined by quantitative real time RT-PCR and western blot analysis, respectively, and GFP expression was monitored by fluorescence microscopy.
Cells from the mouse calvaria-derived non-transformed pre-osteoblast cell line MC3T3-E1 (subclone 4; ATCC, Rockville, MD: designated as MC3T3 cells), were transfected with pCMV-GLI(-)TAD: a human GLI1 cDNA lacking a t rans a ctivation d omain and cloned into pcDNA3 plasmid (kindly provided by Drs. Joon Won Yoon and David Walterhouse, Children's Memorial Research Center, Northwestern University Feinberg School of Medicine, Chicago, IL). The pCMV-GLI(-)TAD was previously prepared by deleting a 1,409-bp AccI fragment from the 3' end of human GLI1 cDNA . MC3T3 cells were transfected with 3 μg DNA using the Effectene reagent according to manufacturer's protocol (Qiagen), selected for stable transfection with G418 (Sigma), and cloned by limiting dilution (designated M-TAD cells). Parental MC3T3 and M-TAD cells were maintained at 37C, 5% CO2 in non-differentiation complete culture medium consisting of ascorbic acid (AA)-free α-MEM supplemented with 10% FBS, 100 U/ml penicillin and 100 μg/ml streptomycin (Gibco Invitrogen).
Mixed Culture of Cells
Control LNCaP or LNShh cells (5 × 104) and MC3T3 cells (0.5 × 104) were mixed in AA-free α-MEM complete culture medium and seeded per well of 6-well tissue culture plates. Cultures were maintained for the length of time specified in the experiments with media changes every 2–3 days.
Separate Co-culture of Cells
Control LNCaP or LNShh cells (5 × 104) were seeded per cell culture insert (transparent PET membrane, 0.4 μm pore size: BD Biosciences) in RPMI-1640 complete culture medium. MC3T3 cells (1 × 104) were seeded per well of 6-well tissue culture plates in AA-free α-MEM complete culture medium. After two days, culture inserts grown with prostate cancer cells were transferred to wells grown with MC3T3 cells, and co-cultures were maintained in AA-free α-MEM complete culture medium for the length of time specified in the experiments with media changes every 2–3 days.
RNA Isolation and Real Time Quantitative RT-PCR
Total RNA was extracted using Trizol (Invitrogen), purified using the RNeasy Mini Kit (Qiagen) and subjected to DNase treatment with RQ1 RNase-free DNase (Promega) to remove contaminating genomic DNA. The TaqMan® Gold PCR Core Reagent Kit along with MuLV Reverse Transcriptase and RNase Inhibitor (Applied Biosystems) were used for cDNA synthesis. PCR primers (Invitrogen) and FAM-QSY7 probes (MegaBases, Inc.) for genes of interest and the housekeeping gene glyceraldehyde-3-phosphate dehydrogenase (Gapdh), whose sequences are shown in Table 1, were designed using the Primer Express 3.0 software program. mRNA expression was measured in duplicate or triplicate per sample using 40 cycles of amplification in the 7500 Fast Real-Time PCR System (Applied Biosystems). Reactions were routinely performed without Reverse Transcriptase to demonstrate RNA dependence of the reaction products. Results were analyzed using the comparative Ct method. Ct is the threshold cycle at which the reporter fluorescence signal for each amplicon passes above a fixed baseline. The average Ct of the gene of interest was normalized to that of the housekeeping gene Gapdh to obtain the ΔCt for that gene. ΔCt values between experimental and control samples were then compared (ΔΔCt) to reflect the relative fold change in gene expression.
Cell Proliferation Assay
Cells were maintained as separate co-cultures as described above. MC3T3 cells were seeded onto 24-well tissue culture plates at 0.2 × 104 cells per well. Control LNCaP or LNShh cells were seeded at 2 × 104 cells per cell culture insert. Following overnight incubation, culture inserts were transferred to wells and co-cultures were maintained in AA-free α-MEM complete culture medium with media changes every 2–3 days. At specified times, cell inserts were removed and proliferation of MC3T3 cells grown on wells was determined using the Cell Counting Kit-8 (Dojindo Laboratories, Japan) which is based on the formation of a water-soluble formazan dye through the activity of dehydrogenases in living cells.
Immunocytochemistry and Immunofluorescence
Cells were maintained as mixed cultures in Lab-TekII CC2-treated chamber slides (Nunc) for the length of time specified in the experiments with media changes every 2–3 days. Cells were then fixed in 10% neutral buffered formalin for 10 minutes and permeated with 0.1% Triton X-100. For fluorescence immunocytochemistry, cells were stained with Alexa Flour 635 Phalloidin (Invitrogen: 1:40 dilution) and incubated in the dark for 20 minutes. Cells were counter-stained with 300 nM DAPI (Invitrogen). Slides were mounted using ProLong Gold antifade reagent (Invitrogen). For cytokeratin expression, fixed cells were stained with mouse monoclonal anti-human cytokeratin 8 antibody (DAKO: 1:50 dilution), developed with diaminobenzidine, and counterstained with hematoxylin. Slides were viewed in a Leica DMR-HC Upright Microscope and images were captured with imaging software (Improvision Openlab). Fluorescent images were captured at the following excitation/emission wavelengths (nm): Phalloidin-560/645; DAPI-360/470; GFP-480/527.
Alkaline Phosphatase Activity
Quantitative determination of ALP activity was done using the p-Nitrophenyl Phosphate (pNPP) Liquid Substrate System according to manufacturer's protocol (Sigma Aldrich). Briefly, cells in culture wells were treated with 0.2% Triton X-100, harvested with a cell scraper, and subjected to freeze-thaw cycles. Lysates were centrifuged and supernatants (10 μg protein) were incubated with 150 μl pNPP for 5 h at room temperature in the dark. Absorbance at 405 nm was measured using a microplate reader, and ALP activity was calculated according to manufacturer's instructions. Protein determination was done using the Bio-Rad DC Protein Microplate Assay according to manufacturer's protocol.
For ALP staining, mixed cultures were fixed with 10% neutral buffered formalin for 10 minutes and incubated with alkaline phosphatase substrate solution for at least 30 minutes at room temperature in the dark. The substrate solution was prepared by adding Naphthol AS-MX Phosphate Alkaline Solution to a diazonium salt solution (Fast Violet B Salt capsule dissolved in distilled water) just before use (Sigma-Aldrich).
Effect of Shh peptide
MC3T3 cells were seeded onto 6-well culture plates at 1 × 105 cells per well in AA-free α-MEM complete culture medium. Following overnight incubation, cells were treated with 1 μg/ml Shh-N, a modified active N-terminal peptide of human Shh (kindly provided by Curis Inc., Cambridge, MA), in serum-free AA-free α-MEM culture media for 24 h or 72 h.
Inhibition of Shh Signalling by Cyclopamine
Cultures of mixed cells (as described above) were maintained for 6 days in serum-free AA-free α-MEM culture medium with 1 or 10 μM cyclopamine (vehicle controls were 0.01 or 0.1% ethanol, respectively). Cyclopamine, a generous gift from Dr. W. Gaffield (Western Regional Research Center, USDA, Albany, CA), has been previously used to inhibit Shh signalling in developing mouse prostate .
Effect of Ascorbic Acid
Cultures of mixed cells (as described above) were maintained for 7 days in AA-free α-MEM complete culture medium without or with 50 μg/ml L-ascorbic acid (AA; Sigma). To determine the direct effect of AA, MC3T3 cells were seeded alone onto 6-well culture plates at 1 × 105 cells per well in AA-free α-MEM complete culture medium. Following overnight incubation, cells were treated without or with 50 μg/ml AA for 24 h.
Data were analyzed by ANOVA and pairwise multiple comparisons were done using the Bonferroni t-test at P < 0.05. Data are presented as means ± SD of at least 2 assays from independent experiments, each assay done in duplicate or triplicate.
We thank Joonho Park for help with statistical analysis. We thank colleagues mentioned in Methods for generously providing plasmids and reagents. This work was supported by grants from the National Cancer Institute, Career Development Award (MLGL); American Cancer Society (MLGL); Illinois Regenerative Medicine Institute (MLGL and PMI); and George M. Eisenberg Foundation for Charities (PMI).
- Bubendorf L, Schöpfer A, Wagner U, Sauter G, Moch H, Willi N, Gasser TC, Mihatsch MJ: Metastatic patterns of prostate cancer: an autopsy study of 1, 589 patients. Hum Pathol. 2000, 31: 578-583. 10.1053/hp.2000.6698View ArticlePubMedGoogle Scholar
- Berruti A, Dogliotti L, Bitossi R, Fasolis G, Gorzegno G, Bellina M, Torta M, Porpiglia F, Fontana D, Angeli A: Incidence of skeletal complications in patients with bone metastatic prostate cancer and hormone refractory disease: predictive role of bone resorption and formation markers evaluated at baseline. J Urol. 2000, 164: 1248-1253. 10.1016/S0022-5347(05)67149-2View ArticlePubMedGoogle Scholar
- Clark PE, Torti FM: Prostate cancer and bone metastases: medical treatment. Clin Orthop Relat Res. 2003, 415S: S148-S157. 10.1097/01.blo.0000093840.72468.e1.View ArticleGoogle Scholar
- Paget S: The distribution of secondary growths in cancer of the breast. Lancet. 1889, 1: 571-573. 10.1016/S0140-6736(00)49915-0.View ArticleGoogle Scholar
- Keller ET, Zhang J, Cooper CR, Smith PC, McCauley LK, Pienta KJ, Taichman RS: Prostate carcinoma skeletal metastases: cross-talk between tumor and bone. Cancer Metastasis Rev. 2001, 20: 333-349. 10.1023/A:1015599831232View ArticlePubMedGoogle Scholar
- Edlund M, Sung S-Y, Chung LWK: Modulation of prostate cancer growth in bone microenvironments. J Cell Biochem. 2004, 91: 686-705. 10.1002/jcb.10702View ArticlePubMedGoogle Scholar
- Cohen MM: The hedgehog signaling network. Am J Med Genet. 2003, 123A: 5-28. 10.1002/ajmg.a.20495.View ArticlePubMedGoogle Scholar
- Iannaccone P, Holmgren R, Lamm MLG, Ahlgren S, Lakiza O, Yoon JW, Walterhouse D: The sonic hedgehog signaling pathway. Inborn Errors of Development. Edited by: Epstein CJ, Erickson RP, Wynshaw-Boris A. 2008, 263-279. Oxford University Press, 2.Google Scholar
- Fan L, Pepicelli CV, Dibble CC, Catbagan W, Zarycki JL, Laciak R, Gipp J, Shaw A, Lamm MLG, Munoz A, Lipinski R, Thrasher JB, Bushman W: Hedgehog signaling promotes prostate xenograft tumor growth. Endocrinology. 2004, 145: 3961-3970. 10.1210/en.2004-0079View ArticlePubMedGoogle Scholar
- Karhadkar SS, Bova GS, Abdallah N, Dhara S, Gardner D, Maitra A, Issacs JT, Berman DM, Beachy PA: Hedgehog signaling in prostate regeneration, neoplasia and metastasis. Nature. 2004, 431: 707-712. 10.1038/nature02962View ArticlePubMedGoogle Scholar
- Sanchez P, Hernández AM, Stecca B, Kahler AJ, DeGueme AM, Barrett A, Beyna M, Datta MW, Datta S, Ruiz i Altaba A: Inhibition of prostate cancer proliferation by interference with SONIC HEDGEHOG-GLI1 signaling. Proc Natl Acad Sci USA. 2004, 101: 12561-12566. 10.1073/pnas.0404956101PubMed CentralView ArticlePubMedGoogle Scholar
- Sheng T, Li C, Zhang X, Chi S, He N, Chen K, McCormick F, Gatalica Z, Xie J: Activation of the hedgehog pathway in advanced prostate cancer. Mol Cancer. 2004, 3: 29-41. 10.1186/1476-4598-3-29PubMed CentralView ArticlePubMedGoogle Scholar
- Walterhouse DO, Lamm MLG, Villavicencio E, Iannaccone PM: Emerging roles for Hedgehog-Patched-Gli signal transduction in reproduction. Biol Reprod. 2003, 69: 8-14. 10.1095/biolreprod.103.015941View ArticlePubMedGoogle Scholar
- Lamm MLG, Bushman W: Hedgehog signalling in prostate morphogenesis. Shh and Gli Signalling and Development. Edited by: Fisher CE, Howie SEM. 2006, 116-124. Landes Bioscience, Austin and Springer, New York.Google Scholar
- Quarles LD, Yohay DA, Lever LW, Caton R, Wenstrup RJ: Distinct proliferative and differentiated stages of murine MC3T3-E1 cells in culture: an in vitro model of osteoblast development. J Bone Miner Res. 1992, 7: 683-692.View ArticlePubMedGoogle Scholar
- Yoon JW, Liu CZ, Yang JT, Swart R, Iannaccone P, Walterhouse D: GLI activates transcription through a herpes simplex viral protein 16-like activation domain. J Biol Chem. 1998, 273: 3496-3501. 10.1074/jbc.273.6.3496View ArticlePubMedGoogle Scholar
- Ducy P, Zhang R, Geoffroy V, Ridall AL, Karsenty G: Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell. 1997, 89: 747-754. 10.1016/S0092-8674(00)80257-3View ArticlePubMedGoogle Scholar
- Karsenty G: Role of Cbfa1 in osteoblast differentiation and function. Semin Cell Dev Biol. 2000, 11: 343-346. 10.1006/scdb.2000.0188View ArticlePubMedGoogle Scholar
- Franceschi RT, Iyer BS, Cui Y: Effects of ascorbic acid on collagen matrix formation and osteoblast differentiation in murine MC3T3-E1 cells. J Bone Miner Res. 1994, 9: 843-854.View ArticlePubMedGoogle Scholar
- Xiao G, Cui Y, Ducy P, Karsenty G, Franceschi RT: Ascorbic acid-dependent activation of the osteocalcin promoter in MC3T3-E1 preosteoblasts: requirement for collagen matrix synthesis and the presence of an intact OSE2 sequence. Mol Endocrinol. 1997, 11: 1103-1113. 10.1210/me.11.8.1103View ArticlePubMedGoogle Scholar
- Kinto N, Iwamoto M, Enomoto-Iwamoto M, Noji S, Ohuchi H, Yoshioka H, Kataoka H, Wada Y, Yuhao G, Takahashi HE, Yoshiki S, Yamaguchi A: Fibroblasts expressing Sonic hedgehog induce osteoblast differentiation and ectopic bone formation. FEBS Lett. 1997, 404: 319-323. 10.1016/S0014-5793(97)00014-8View ArticlePubMedGoogle Scholar
- Nakamura T, Aikawa T, Iwamoto-Enomoto M, Iwamoto Masahiro, Higuchi Y, Maurizio P, Kinto N, Yamaguchi A, Noji S, Kurisu K, Matsuya T: Induction of osteogenic differentiation by hedgehog proteins. Biochem Biophys Res Commun. 1997, 237: 465-469. 10.1006/bbrc.1997.7156View ArticlePubMedGoogle Scholar
- Yuasa T, Kataoka H, Kinto N, Iwamoto M, Enomoto-Iwamoto M, Iemura S-I, Ueno N, Shibata Y, Kurosawa H, Yamaguchi A: Sonic hedgehog is involved in osteoblast differentiation by cooperating with BMP-2. J Cell Physiol. 2002, 193: 225-232. 10.1002/jcp.10166View ArticlePubMedGoogle Scholar
- Jemtland R, Divieti P, Lee K, Segre GV: Hedgehog promotes primary osteoblast differentiation and increases PTHrP mRNA expression and iPTHrP secretion. Bone. 2003, 32: 611-620. 10.1016/S8756-3282(03)00092-9View ArticlePubMedGoogle Scholar
- van der Horst G, Farih-Sips H, Löwik CWGM, Karperien M: Hedgehog stimulates only osteoblastic differentiation of undifferentiated KS483 cells. Bone. 2003, 33: 899-910. 10.1016/j.bone.2003.07.004View ArticlePubMedGoogle Scholar
- Zhao M, Qiao M, Harris SE, Chen D, Oyajobi BO, Mundy GR: The zinc finger transcription factor Gli2 mediates bone morphogenetic protein 2 expression in osteoblasts in response to hedgehog signaling. Mol Cell Biol. 2006, 26: 6197-6208. 10.1128/MCB.02214-05PubMed CentralView ArticlePubMedGoogle Scholar
- Shimoyama A, Wada M, Ikeda F, Hata K, Matsubara T, Nifuji A, Noda M, Amano K, Yamaguchi A, Nishimura R, Yoneda T: Ihh/Gli2 signaling promotes osteoblast differentiation by regulating Runx2 expression and function. Mol Biol Cell. 2007, 18: 2411-2418. 10.1091/mbc.E06-08-0743PubMed CentralView ArticlePubMedGoogle Scholar
- Walterhouse D, Ahmed M, Slusarski D, Kalamaras J, Boucher D, Holmgren R, Iannaccone P: gli, a zinc finger transcription factor and oncogene, is expressed during normal mouse development. Dev Dyn. 1993, 196: 91-102.View ArticlePubMedGoogle Scholar
- Bitgood MJ, McMahon AP: Hedgehog and Bmp genes are coexpressed at many diverse sites of cell-cell interaction in the mouse embryo. Dev Biol. 1995, 172: 126-138. 10.1006/dbio.1995.0010View ArticlePubMedGoogle Scholar
- Vortkamp A, Lee K, Lanske B, Segre GV, Kronenberg HM, Tabin CJ: Regulation of rate of cartilage differentiation by Indian hedgehog and PTH-related protein. Science. 1996, 273: 613-622. 10.1126/science.273.5275.613View ArticlePubMedGoogle Scholar
- Mo R, Freer AM, Zinyk DL, Crackower MA, Michaud J, Heng HH-Q, Chik KW, Shi X-M, Tsui L-C, Cheng SH, Joyner AL, Hui C-c: Specific and redundant functions of Gli2 and Gli3 zinc finger genes in skeletal patterning and development. Development. 1997, 124: 113-123.PubMedGoogle Scholar
- St-Jacques B, Hammerschmidt M, McMahon AP: Indian hedgehog signaling regulates proliferation and differentiation of chondrocytes and is essential for bone formation. Genes Dev. 1999, 13: 2072-2086. 10.1101/gad.13.16.2072PubMed CentralView ArticlePubMedGoogle Scholar
- Chung U-i, Schipani E, McMahon AP, Kronenberg HM: Indian hedgehog couples chondrogenesis to osteogenesis in endochondral bone development. J Clin Invest. 2001, 107: 295-304. 10.1172/JCI11706PubMed CentralView ArticlePubMedGoogle Scholar
- Long F, Chung U-i, Ohba S, McMahon J, Kronenberg HM, McMahon AP: Ihh signaling is directly required for the osteoblast lineage in the endochondral skeleton. Development. 2004, 131: 1309-1318. 10.1242/dev.01006View ArticlePubMedGoogle Scholar
- Colnot C, de la Fuente L, Huang S, Hu D, Lu C, St-Jacques B, Helms JA: Indian hedgehog synchronizes skeletal angiogenesis and perichondrial maturation with cartilage development. Development. 2005, 132: 1057-1067. 10.1242/dev.01649View ArticlePubMedGoogle Scholar
- Yoon JW, Kita Y, Frank DJ, Majewski RR, Konicek BA, Nobrega MA, Jacob H, Walterhouse D, Iannaccone P: Gene expression profiling leads to identification of GLI1-binding elements in target genes and a role for multiple downstream pathways in GLI1-induced cell transformation. J Biol Chem. 2002, 277: 5548-5555. 10.1074/jbc.M105708200View ArticlePubMedGoogle Scholar
- Komori T, Yagi H, Nomura S, Yamaguchi A, Sasaki K, Deguchi K, Shimizu Y, Bronson RT, Gao Y-H, Inada M, Sato M, Okamoto R, Kitamura Y, Yoshiki S, Kishimoto T: Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell. 1997, 89: 755-764. 10.1016/S0092-8674(00)80258-5View ArticlePubMedGoogle Scholar
- Otto F, Thornell AP, Crompton T, Denzel A, Gilmour KC, Rosewell IR, Stamp GWH, Beddington RSP, Mundlos S, Olsen BR, Selby PB, Owen MJ: Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell. 1997, 89: 765-771. 10.1016/S0092-8674(00)80259-7View ArticlePubMedGoogle Scholar
- Xiao G, Gopalakrishnan R, Jiang D, Reith E, Benson MD, Franceschi RT: Bone morphogenetic proteins, extracellular matrix, and mitogen-activated protein kinase signaling pathways are required for osteoblast-specific gene expression and differentiation in MC3T3-E1 cells. J Bone Miner Res. 2002, 17: 101-110. 10.1359/jbmr.2002.17.1.101View ArticlePubMedGoogle Scholar
- Spinella-Jaegle S, Rawadi G, Kawai S, Gallea S, Faucheu C, Mollat P, Courtois B, Bergaud B, Ramez V, Blanchet AM, Adelmant G, Baron R, Roman-Roman S: Sonic hedgehog increases the commitment of pluripotent mesenchymal cells into the osteoblastic lineage and abolishes adipocytic differentiation. J Cell Sci. 2001, 114: 2085-2094.PubMedGoogle Scholar
- Liao J, McCauley LK: Skeletal metastasis: Established and emerging roles of parathyroid hormone related protein (PTHrP). Cancer Metastasis Rev. 2006, 25: 559-571. 10.1007/s10555-006-9033-zView ArticlePubMedGoogle Scholar
- Bailey JM, Singh PK, Hollingsworth MA: Cancer metastasis facilitated by developmental pathways: Sonic hedgehog, Notch, and Bone morphogenetic proteins. J Cell Biochem. 2007, 102: 829-839. 10.1002/jcb.21509View ArticlePubMedGoogle Scholar
- Lamm MLG, Catbagan WS, Laciak RJ, Barnett DH, Hebner CM, Gaffield W, Walterhouse D, Iannaccone P, Bushman W: Sonic hedgehog activates mesenchymal Gli1 expression during prostate ductal bud formation. Dev Biol. 2002, 249: 349-366. 10.1006/dbio.2002.0774View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.